Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer

Clinical trial NCT06284746 · UNKNOWN

Trial details

NCT number: NCT06284746
Sponsor: Lin Chen
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Gastric Carcinoma HER2 Negative Efficacy Safety

Start date: 2023-10-01
Primary completion: 2025-04-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.